Status: current, Defined. Date: 30-Jun 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 149001000036114 | Topotecan (Kabi) (topotecan 4 mg) powder for injection, 5 x 4 mg vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 149021000036116 | Topotecan (Kabi) 4 mg powder for injection, 5 vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Topotecan (Kabi) 4 mg powder for injection, 5 vials | Is a | trade product pack | true | Inferred relationship | Some | ||
| Topotecan (Kabi) 4 mg powder for injection, 5 vials | Is a | topotecan 4 mg injection, 5 vials | true | Inferred relationship | Some | ||
| Topotecan (Kabi) 4 mg powder for injection, 5 vials | has TPUU | Topotecan (Kabi) 4 mg powder for injection, 4 mg vial | true | Inferred relationship | Some | 1 | |
| Topotecan (Kabi) 4 mg powder for injection, 5 vials | has TP | Topotecan (Kabi) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Topotecan (Kabi) 4 mg powder for injection, 5 vials | Is a | True | Topotecan (Kabi) 4 mg powder for injection, 5 vials | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR